A judge orders a 12-year old girl with Chronic Fatigue Syndrome /Myalgic Encephalomyelitis (CFS/ME) and Multiple Chemical Sensitivity (MCS) to be locked up in a psychiatric ward of a hospital and forbids her mother to see her. We are calling on everyone to support this family and to help us with the legal costs.

THE FACTS

Last Saturday August 5, 2011, two plain-clothes policemen went to the home of V.R., a 46 year-old woman who has severe CFS/ME, MCS and Fibromyalgia, and took her 12 year-old daughter (who also has CFS/ME and MCS) with a judge’s order which stated that the girl had to be hospitalized in the psychiatric ward of the local hospital in central Spain and to keep the mother from seeing her.

THE BACKGROUND

The mother, V.R., who is very ill herself, has been fighting for years against the local Social Services. She had been denounced by the School Board for her daughter missing a lot of school, although a judge pronounced himself in favour of the mother and forced the school board to send a teacher to the girl’s home for schooling due to her severe CFS/ME and MCS.

Both the mother and the daughter were forced by Social Services to go once a week to a psychologist, although the physical effort of going to the appointments made them even more ill. The homecare that they were entitled to also made them sicker, as the home-care workers did not respect their needs for environmental control and they entered their home wearing perfume and smelling of tobacco.

When the mother complained about this, Social Services, instead of taking into account their special needs, saw it as “the last straw” and they decided to cancel their home service and proceeded to accuse the mother of “isolating” her daughter, which led to having the girl taken away.

MEDICAL REPORTS

The fact that V.R. and her daughter have been diagnosed by three of Spain’s leading CFS/ME specialists (and one of them also is an MCS specialist), Dr Jose Alegre, Dr Joaquín Fernandez-Sola and Dr Ana Garcia Quintana, as having severe CFS/ME and MCS with lab tests to prove it, (like alteration in their immunological parameters, high RnaseL and viral reactivations), is being ignored by the Social Services in that region of Spain. They say that the medical evaluation is going to be done by the local psychiatrists.

THE SITUATION RIGHT NOW

Yesterday, the judge ordered an “indefinite hospitalization of the girl in the psychiatric ward of the local hospital and forbid the mother to go see her, alleging that any contact with the mother would be bad for the girl’s health”.

Now the girl is in the hands of psychiatrists who are trying to prove that mother and daughter have a joint delirious alteration and are suffering from Munchhausen Syndrome, leaving the mother unfit to look after her daughter.

HOW YOU CAN HELP

Faced with this situation, we, three Spanish CFS/ME and MCS associations, have joined efforts from day one to support this girl and her mother on all levels: legal, logistic, medical, etc. But we need financial support. The mother gets a 400 Euro-a-month pension (equivalent to 350 British Pounds or 569 US Dollars) on which her and her daughter try to live on. They don’t have the funds to pay for the lawyers who are now working on their case to try to get the girl out of the hospital, reunite her with her mother and assure that she does not lose her custody battle with the Social Services. We have been footing the bills up to know but our associations don’t have funding.

Right now, because of the delicate work being done by lawyers, we do not want to put direct pressure on the Social Services ourselves and the lawyers say that right now, any public or press pressure on this case might back-fire. But as soon as the lawyers give us the go-ahead, we will start a massive public pressure campaign and we will let you know how you can join in that effort.

For now, we just want to let you know of this unfolding situation and to ask for any possible financial support you can give.

We are just starting this battle

and

WE WILL NOT ALLOW THEM TAKE OUR CHILDREN WITH CFS/ME OR MCS AWAY SAYING THAT THEY HAVE MENTAL PROBLEMS.

Thank you from all of us.

Clara Valverde

President

Liga SFC, Spain, August 12, 2011

www.ligasfc.org

formacionsalud@hotmail.com (any messages for mother and daughter in English can be sent to this e-address for translation before passing it on to them)

Francisca Gutierrez

President

ASQUIFYDE, Spain

www.asquifyde.es

Jose Luis Rivas

President

ASSSEM

www.asssem.org

For international donations, the bank account number is:

(if you are making a donation from Europe):

ES80 1465 0100 91 1700515969

(if you are making a donation from a country outside Europe):

INGDESMMXXX 1465 0100 91 1700515969

(if you are making a donation from Spain):

1465 0100 91 1700515969

WASHINGTON, Friday, December 03, 2010 — At present, there are no specific federal recommendations regarding deferral of individuals with Chronic Fatigue Syndrome (CFS) or other diseases that have been associated with Murine Leukemia Virus-related virus (XMRV) infection. Nevertheless, in the interest of patient and donor safety, the American Red Cross will defer indefinitely any donor who reveals during the donor interview that they have been diagnosed with CFS.

XMRV infection has been associated in some studies with prostate cancer and chronic fatigue syndrome, but at the present time these disease associations have yet to be confirmed.

There is currently insufficient data to conclude that XMRV is transmitted through blood transfusion. However, the National Heart, Lung and Blood Institute (NHLBI) Task force is conducting research to determine the frequency of the virus in the donor population, whether it is transfusion-transmitted, and whether recipients become infected and develop the disease.

An AABB Interorganizational Task Force is charged with reviewing all available data, making recommendations for further action to assess the risk of XMRV transmission through blood transfusion, develop mitigation strategies as needed, and to provide information for blood donors, recipients and the public.

The AABB Taskforce released Association Bulletin #10-03 in June 2010, recommending that blood collecting organizations — through the use of donor education materials available at the donation site — actively discourage potential donors who have ever been diagnosed by a physician with chronic fatigue syndrome (CFS), also known as chronic fatigue and immune dysfunction syndrome (CFIDS) or myalgic encephalomyelitis (ME), from donating blood or blood components. In addition, any donor with symptoms of CFS would be deferred if, on the day of donation, they respond negatively to the question, “Are you feeling well today?”

The Red Cross has implemented the AABB recommendations and has gone further to implement indefinite deferral for donors who reveal a history of a medical diagnosis of CFS.

Reference:

Red Cross National Headquaters, American Red Cross Statement on XMRV and Chronic Fatigue Syndrome, December 03, 2010

Releated article:

CFS Finally Recognized As ‘Medical Impairment’ Under Guidelines

Daily chemical exposures at low doses can affect our health

ROME – On September 24, 2010, from 8:30 a.m. to 5:30 p.m., the congress “New Environmental Diseases” was held at the Chamber of Deputees Congress Hall in Rome. The event was organized by A.M.I.C.A. (Association for Environmental and Chronic Toxic Injury), the Italian organization that works for the rights of people with MCS and EHS, and it was supported by Mep Domenico Scilipoti, an oncologist, holistic doctor, and rapporteur of a draft to become law on environmental diseases and disabilities and also for the phasing out of dental amalgam.

“More and more scientific evidence shows how daily chemical exposures at low doses can affect our health. With this event we would like to create a bridge between science and politics in order to have a new legislation, particularly for the protection of those affected by Multiple Chemical Sensitivity, Electromagnetic Hyper Sensitivity, Chronic Fatigue Syndrome and Fibromyalgia. These diseases seem to be correlated one to another,” Francesca Romana Orlando, Vice President of A.M.I.C.A., commented. She has just published the book Il Cerchio Perfetto (The Perfect Circle) about the link between industry, politics, academics, and media and its role in the hiding of toxic dangers to the public.

“Just a few weeks ago, at the Senate Commission for Health, the debate about the draft to become law for the recognition of MCS as an epidemic disease started. The prevalence of this illness is about 10% of the population and in Italy the patients still don’t have any hospital to receive any medical treatment in a proper environment,” Silvia Bigeschi, Vice President of A.M.I.C.A., adds.

There are ten projects to become law for the recognition of MCS as an epidemic disease at the Italian Parliament and, just the day before of the congress, A.M.I.C.A. presented a petition with more than 10,000 signature asking for the approval of a law for MCS and also a petition to the Ministry of Health for the total phase out of dental mercury (amalgam), since many cases of MCS, CFS and EHS seem to be triggered by amalgam fillings.

The congress was divided in four sessions. The first one was about “Diagnostic approaches” for MCS, CFS and FM. Prof. Giuseppe Genovesi of the University of Rome La Sapienza and Dr. Chiara De Luca, Head of the Laboratory BILARA at the Dermatological Institute Immacolata of Rome, presented the results of a study on oxidative stress and genetics in MCS patients, that was recently published on Toxicology Applied Pharmacology (Apr. 26, 2010).

While Dr. De Luca focused on the clear evidence of oxidative stress in these patients, such as the lack of enzyme catalysis and GST, Prof. Genovesi stressed the fact that the results don’t show the prevalence of one specific genetic polymorphism, but most of the patients had one or more genetic factors inducing a lower detoxification. He also announced that they are going to test the genetic predisposition of the enzyme catalysis, since this is so typically low in MCS patients.

Dr. Alberto Migliore, the chief of Rheumatology Department at the S. Pietro Fatebenefratelli Hospital in Rome, published a study about the comorbidity of MCS and Sjogren Syndrome. Dr. Lorenzo Bettoni presented a lecture about the environmental causes of CFS and FM, with an hypothesis about the role of chemicals, EMF pollution, and physical/mental stress on the triggering of these illnesses.

Dr. Giacomo Rao, who works for the Italian National Insurance of Workers (INAIL, the public institute that gives compensation and pension to the workers injured at workplace), talked about the legal aspects of the recognition of these illnesses as a disability. He showed that there are several impact life factors to consider and that in Italy there are now many MCS disability certificates, even if it is always very difficult to convince the commissions about the severity of this illness. He added that the final judgment depends only on the good will of the commissioners to study a new issue.

In the second session entitled “New Paradigms of Toxicology and Environmental Medicine,” Martin L. Pall, Professor Emeritus of Biochemistry and Basic Medical Sciences, Washington State University, presented his theory about the biochemical vicious cycle ON/ONOO – induced by the combination of high NOS activity and Tetrahydrobiopterin (BH4) depletion – and how it is able to explain not only MCS, CFS or FM, but also other emerging neuro-degenerative illnesses such AD, Parkinson or ALS. He commented that the De Luca – Genovesi study about oxidative stress represents a full confirmation of his theory.

Dr. Peter Ohnsorge, President of the European Academy for Environmental Medicine (EUROPAEM), has already applied Pall’s theory to his clinical approach in order to reduce NMDA in the cerebral metabolism. He proceeds in treating inflammation first, by supplementing enzymes, antioxidants, minerals and Vitamins. Then, he offers a chelation therapy, when possible, and also hemapheresis (Membrane Differential Filtration), gut therapy and detoxification. He also uses sauna therapy since the heat helps to increase BH4 and to oppose the vicious NO/ONOO cycle.

Recently, Dr. Ohnsorge was commissioned by the German Ministry of Health and Social Affairs, to do a controlled randomized study about the efficacy of therapies for MCS patients with the double aim of detoxification of lipophilic toxins and improving the complaints. He found out that using a complex therapeutic regime usually allows the patients to recover slowly, but surely.

The MCS people in the audience asked him several questions, for example about the bad secondary effects of supplementation of glutathione (GSH) and about the tests of compatibility of drugs and dental materials. He explained that supplementation has to be given always with very low doses at the beginning in order to avoid violent breaks in the detoxification mechanisms. Moreover, he suggested using the Lymphocyte Transformation Test (LTT) to find out reactions to drugs, metals, plastics and environmental toxins, while the basophil degranulation test is suggested when inflammation is suspected induced by metals, like in the case of titanium implants.

In the same second session, Dr. Ernesto Burgio, Coordinator of the Scientific Committee of ISDE Italia (Doctors for the Environment), gave a lecture about the epigenetic damages caused by environmental toxins and EMFs. The epigenome represents the interface between the information from the environment and the genome, and even in the absence of chromosomal or gene mutations, there still can be a change in the expression of the gene (DNA Methylation) because of an epigenetic injury. “With a few exceptions, cellular differentiation almost never involves a change in the DNA sequence itself,” commented Dr. Burgio.

Since the environment changed too quickly in the latest decades, the capacity of adaptation of the (epi) genome is not enough to compensate it. Thus, a toxic exposure from the parents, in the womb, or during the early childhood can induce a chronic disabling illness later in life.

New studies are being explored on how a lead exposure in infants can be associated to Alzheimer’s disease (AD)-like symptoms years later or how the mother’s exposure to high levels of folic acid, vitamin B12 or to cigarette smoke can induce epigenetic changes that can repress gene transcription and, then, induce phenotypes of asthma (i.e. allergic airway inflammation) in the offspring. These findings could lead to the conclusion that our society is on the edge of a “disevolution.”

In the third section on “Heavy Metals Toxicity,” Dr. Raimondo Pische, President of the International Academy of Bio-Dentistry (AIOB) talked about the risks associated with the exposure to the metals of dental amalgam. In particular, he presented a video of an amalgam fillings showing how mercury vapors are easily released by the amalgam. He underlined the fact that the dentists are the first ones at risk when they pose and remove amalgam fillings and that dental mercury represents the main source of exposure to mercury vapors in not occupational environments. This is no longer acceptable since mercury is the most toxic element in nature after the radioactive elements.

Dr. Antonello Maria Pasciuto, Italian member of the European Academy for Environmental Medicine (EUROPAEM), talked about the LTT-MELISA, the Lymphocyte Transformation Test for the proof of late allergy to metals (type IV). This kind of allergy was observed in patients with MCS, CFS, MS, FM, ALS and autoimmune diseases and it usually improves, as well as the symptoms, after the safe removal of dental metals.

Dr. Gianpaolo Guzzi of the Italian Organization for the Research on Metals and Biocompatibility (A.I.R.M.E.B.) talked about the side effects of chelation therapies. His group studied hundreds of patients with amalgam toxic load and they reviewed the effects of EDTA, DMPS, DMSA and Glutathione. EDTA seems to redistribute metals without really getting rid of them, while DMPS seems more effective on treating elemental mercury, but with severe side effects in some cases. DMSA works to detoxify from methyl mercury and it can also get rid of elemental mercury stocked in the kidneys. Recently Dr. Guzzi’s research group is testing the efficacy of Glutathione in metal detoxification since there aren’t studies about it.

In the last session about “EMF and Health”, Dr. Fiorenzo Marinelli, researcher of the Institute of Molecular Genetics (IGM) in Bologna talked about wireless technologies such as mobile phones, Wi-Fi and Wi-Max. He pointed out the fact that thermal effects are only a part of the biological effects of EMFs, but still these are the only ones considered by international safety standard limits. There are also other effects induced by the signal information in itself. This explains why, even though UMTS has usually a lower intensity of the signal compared to GSM, it uses a wider band of frequencies, then involving a greater risk of damage in the DNA, as the recent European Reflex study showed. His research group has recently studied the effects of radars and Wi-Fi and the preliminary findings show that both these kind of EMFs promote cell proliferation (2010).

Since scientific literature clearly demonstrates that EMF in our everyday life can induce DNA breakage, genetic deregulation as well as chromosomal breakage, increase of free radicals, alteration of neurotransmitters, memory loss, hypersensitivity-allergy, aging and possibly cancer, Dr. Marinelli supports the reduction of the safety limit of exposure to 0,6 V/m, as requested by the International Commission for the Electromagnetic Safety (ICEMS) since 2002.

Finally, Prof. Olle Johansson, associate professor at The Experimental Dermatology Unit – Department of Neuroscience of the Karolinska Institute, and Professor at The Royal Institute of Technology, Sweden, also member of the famous Bioinitiative Working group, presented a lecture about Electro-Hyper-Sensitivity, which is fully recognized as a functional impairment in Sweden. He explained not only the bioeffects of EMF on EHS people, but also the social problem of disability in our modern societies. “Disability is everywhere and it can happen to anyone: I myself have a disability when I am in Italy because I can not speak Italian,” Prof. Johansson commented. He reminded that all modern democracies signed international equal rights UN treaties, but still they leave these principles un-realized when it comes to environmental disability.

Reference:

A.M.I.C.A. congress shows how environmental and chemical pollution cause health injuries and disabilities, Rome, September 25th, 2010

Photo: AMICA

Contact:

Francesca Romana Orlando
Vice President of AMICA
Associazione Malattie da Intossicazione Cronica e/o Ambientale
(Association for Environmental and Chronic Toxic Injury)
P.O. Box 3131, 00121 Rome – Italy
www.infoamica.it amica(at)infoamica.it

Related articles:

• Predictions of Multiple Chemical Sensitivity Mechanism confirmed by Roman Study
• Martin Pall about genetic evidence and Multiple Chemical Sensitivity
• Italian Parties united under the MCS cause
• An Italian law proposal for Environmental Illness and Disability

Professor Servando Pérez, President of Mercuriados (Spain) and Vice President of the World Alliance for Mercury-Free Dentistry, has put an end to his hunger strike for health reasons. He was carrying out his strike in the Hospital Universitario de Santiago de Compostela, Spain, in order to demand treatment for chronic mercury intoxication. Spain, which is one of the countries in the world which has produced the most mercury, but does not have, in its public health services, doctors nor the facilities to do chelation (the treatment to take toxic metals out of the body) for chronic mercury intoxication. It does however, have chelation for acute mercury intoxication, but that is an easier treatment to do. The lack of proper health services for damage done by toxic metals in Spain is experienced by thousands of people in the country. This was the reason why Servando, had the bravery to strike and show the entire world of this lack of treatment for those compromised by heavy metals.

After Professor Pérez refused to leave the hospital for a month and was on a hunger strike for a week demanding to be treated (as was ordered by a judge when he was diagnosed), the hospital finally came to an agreement to refer him to a toxicologist in Valencia. Yet, this toxicologist has already stated that in Spain there are not any hospitals which can treat chronic mercury intoxication, so the solution to Servando’s situation and for thousands of other people in his situation in Spain is still up in the air. We are now entering into a second phase of this fight which involves meeting with the Spanish Ministry of Health.

We, the Spanish associations of patients with environmental illnesses (Multiple Chemical Sensitivities, Chronic Fatigue Syndrome/Myalgic Encephalitis, Fibromyalgia, Chronic Intoxication by Toxic Metals), continue to fight for appropriate treatments by the public health care system. We want to thank Servando Pérez for his bravery, his coherence, and for being an example for all of us. We know that during his stay in the hospital he was pressured and harassed by doctors and administration, including very aggressive behavior on the part of the psychiatrists who wanted to diagnose him as having a psychiatric disorder.

We also want to thank all the scientists, doctors, associations and individuals who, all over the world, have, during Servando’s lock-in and hunger strike, have contacted the Spanish and the Galician authorities to protest for Servando’s situation and who have shown support for our fight. We hope to continue to count on your support.

We are all Servando!

Viva Servando!

Clara Valverde, President Liga SFC, Spain, August 1, 2010

(on behalf of Servando who is too ill to write)

-

Related articles:

• ALERT: SPANISH PROFESSOR WITH CHRONIC MERCURY INTOXICATION GOES ON HUNGER STRIKE
• Meeting between Ministry of Health and Multiple Chemical Sensitivity associations in Spain
• Cry for help young woman in danger
• MCS – Multiple Chemical Sensitivity recognized as physical disease at ICD-10 in Japan

P.A.N.D.O.R.A. NeuroEndocrineImmune (NEI) Center Resolution Approved by the New Jersey State Senate

Coral Gables, FL, July 17, 2010 –(PR.com)– Resolution SR-20 supporting the establishment of the NeuroEndocrineImmune (NEI) Center™, the first research center in the state of New Jersey and in the U.S., dedicated to understanding and treating chronic neuroendocrineimmune (NEI) illnesses which includes chronic fatigue syndrome, fibromyalgia, multiple chemical sensitivity, Gulf War Illness and other bacterial & viral infections chronic illnesses was passed unanimously by 38-0 votes by the New Jersey State Senate on June 10, 2010.

Senate Resolution (SR) 20, sponsored by Senator Christopher “Kip” Bateman (R), Senate Deputy Conference Leader, and Senator Loretta Weinberg (D), Chair of the Senate Health Committee, cited studies that an estimated 20 million American adults and children suffer with NEIDs. The economic impact and loss of worker productivity in the United States due to CFS/ME, alone, is estimated to be over $9 billion per year. Chronic illness represents 75% of all the health care costs in the U.S.

“It makes sense to locate the NEI center in New Jersey,” said Senator Weinberg. “As the nation’s medicine chest, New Jersey is home to research institutions and private businesses that can cooperate to find a cure for these debilitating diseases.”

Senator Bateman added, “I look forward to the passage of Senate Resolution 20, solidifying legislative support for the research center, and have high hopes that this will, in fact, be a great step forward toward finding answers for the sufferers of these debilitating diseases.”

Assembly Resolution 202 passes unanimously

Late last year, a similar resolution unanimously passed the New Jersey State Assembly 78-0. “Having a research center… is essential to promoting research into the etiology of, and therapeutic interventions for neuroendocrineimmune disorders (NEIDs),” according to Assembly Resolution (AR) 202 which was sponsored by Assemblyman Upendra Chivukula (D), Deputy Speaker; Assemblyman Herb Conaway, Jr. (D), Chairman, Health Committee; Assemblywoman Connie Wagner (D), Vice-Chairman; and Assemblywoman Mary Pat Angelini (R), member of the Health Committee

P.A.N.D.O.R.A. partners with the Lanford Foundation-Lifelyme™, Inc.

To be based in Newark, New Jersey, the NeuroEndocrineImmune (NEI) Center™ is a community patient-driven project of P.A.N.D.O.R.A, (Patient Alliance for Neuroendocrineimmune Disorders Organization for Research & Advocacy, Inc) in partnership with the Lanford Foundation-Lifelyme™, Inc.

The NEI Center™ is the first research center to incorporate scientific and clinical research, quality in patient care, and social services, all in one state-of-the art facility. The establishment of The NEI Center™ is based on the philosophy that the similarities in symptoms of neuroendocrineimmune disorders (NEIDs) are the human body’s response to similarities in the underlying pathophysiologies that cause these disorders.

The cornerstone of the NEI Center’s mission is that discoveries and advances made in any one of the NEIDs will be applicable and beneficial to other NEIDs, thereby bringing medical researchers closer to a cure. At its inception, the NEI Center™ will include research of the following disorders/illnesses:

Chronic fatigue syndrome (CFS), fibromyalgia (FM), Gulf War syndrome or illness (GWS/I), multiple chemical sensitivity (MCS), and other associated bacterial and viral illnesses.

“Moral and political victory,” said Marly Silverman, a CFS and fibromyalgia patient who founded P.A.N.D.O.R.A. in July 1, 2002, “On behalf of P.A.N.D.O.R.A., we are mindful of the historical significance of the unanimous vote by the New Jersey Senate as well as by the New Jersey Assembly in 2009. Patients across this country will be celebrating what is an amazing and pivotal moment in the history of the neuroendocrineimmune disorders community. The New Jersey Legislature has demonstrated a caring commitment to a community of patients who for the first time in the state of New Jersey can look forward to a brighter and fruitful future.”

Veny W. Musum, chairman of the NEI Center Project, who was diagnosed with chronic Lyme disease in 2004 along with his wife, Patricia, added, “The passage of SR 20 is a moral and political victory for millions of individuals stricken with neuroendocrineimmune disorders who have been living far too long without the compassionate support, research and treatment options they deserve. I am proud of my state of New Jersey!”

Advocates Extraordinaire™ & community support

“The overall community support has been outstanding for this patient-driven, physician-approved project. The unanimous votes by each New Jersey senator came about because of the involvement of individuals who participated in the Advocate Extraordinaire™ program, by making calls, writing e-mails and thanking the New Jersey Legislature for their vision and support of the Center,” said Dr. Kenneth Friedman, one of the founding board trustees of the NEI Center, as well as former member of the CFS Advisory Committee, and a member of the Executive Board of P.A.N.D.O.R.A.

“The New Jersey legislators unanimous support for the NEI Center reflects the kind of leadership needed to bring about positive change in our nation’s Health Care,” said Sandi Lanford, Co-founder of the NEI Center™ and the President-Founder of the Lanford Foundation-Lifelyme™, Inc, who was born and raised in New Jersey. The overall community support has been outstanding for this patient-driven, physician- approved project. The unanimous votes by the New Jersey Legislature came about because of the involvement of individuals who participated in the Advocate Extraordinaire™ program, by making calls, writing e-mails and thanking the New Jersey legislators for their vision and support of the Center,” said Dr. Kenneth Friedman, one of the founding board trustees of the NEI Center, as well as former member of the CFS Advisory Committee, and a member of the Executive Board of P.A.N.D.O.R.A.

Dr. Lesley Fein, member of the NEI Center Project team, stated “This center will be a beacon of hope for patients nationwide, and a place which will bring scientific innovation in New Jersey as well as in the rest of the country.”

Present at the passage of the law were Veny Musum, Chairman of the NEI Center Project and Debbie Floyd, team member of the NEI Center™ project.

NEI Center set to open by 2012

The NEI Center founders are already preparing fundraising efforts to make the Center operational by late 2011-early 2012. For more information about The NEI Center™, visit www.neicenter.com.

-

About P.A.N.D.O.R.A., Inc- Patient Alliance for Neuroendocrineimmune Disorders Organization for Research & Advocacy – Based in Coral Gables, Florida, P.A.N.D.O.R.A. was founded on July 1, 2002 by Marly C. Silverman, a chronic fatigue syndrome and fibromyalgia patient. Its mission is to raise awareness of the plight of persons with chronic fatigue syndrome, fibromyalgia, chronic Lyme disease, multiple chemical sensitivities/EI, and Gulf War illness, and advocate on quality of life issues. P.A.N.D.O.R.A.is Built on Hope – Strong on Advocacy – Finding a Cure through Research. For more information, visit www.pandoranet.info.